Company intelligence / Profile preview
Vault Pharma
Los Angeles, California, United States
- Ownership
- Private
- Employees
- ~25
- Development stage
- Other
01
Overview
Vault Pharma is developing a multi-IND immunology platform that uses engineered human vault particles to deliver peptide payloads and elicit strong antigen-specific CD4 and CD8 T-cell responses for oncology, autoimmune, and infectious disease indications; publicly available information indicates preclinical work and collaborations but no disclosed clinical-stage trials yet.[1][2][3]
- Therapeutic areas
- OncologyImmunologyInfectious Diseases
- Modalities
- ProteinNanoparticle
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
UCLA (University of California, Los Angeles)Other academic and government collaboratorsPharmaceutical sector collaborators
Beyond the preview
Go deeper on Vault Pharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Vault Pharma.